Vascular Solutions (VASC) Tops Q1 EPS by 2c

Go back to Vascular Solutions (VASC) Tops Q1 EPS by 2c

Piper Jaffray Raises Price Target on Vascular Solutions (VASC) Following First Earnings Report Since DOJ Litigation

April 26, 2016 8:10 AM EDT

Piper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $45.00 (from $44.00), following the company's 1Q earnings report. VASC reported revenue of $39.4M vs. consensus of $38.5M and adjusted EPS of $0.26 vs. consensus of $0.23. This is the company's first quarterly earnings call since the not-guilty verdict of... More